# Efficacy and Safety of Oral Administration of Postibiotic by FOS Fermentation From Lactobacillus Paracasei in the Treatment of Irritable Bowel Syndrome.

> **NCT06423001** · NA · UNKNOWN · sponsor: **Istituto Clinico Humanitas** · enrollment: 36 (estimated)

## Conditions studied

- IBS - Irritable Bowel Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** PostbiotiX Slowing 4 g sachets PostbiotiX Slowing is a food supplement based on Fermented FOS from Lactobacillus paracasei CNCM I-5220.

## Key facts

- **NCT ID:** NCT06423001
- **Lead sponsor:** Istituto Clinico Humanitas
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-06-15
- **Primary completion:** 2025-05-15
- **Final completion:** 2026-05-15
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2024-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06423001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06423001, "Efficacy and Safety of Oral Administration of Postibiotic by FOS Fermentation From Lactobacillus Paracasei in the Treatment of Irritable Bowel Syndrome.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06423001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*